TIGIT and acute myeloid leukemia: To date, numerous studies have indicated that elevated TIGIT expression is associated with a higher risk of relapse and poor outcomes in AML, regardless of whether allogeneic hematopoietic stem cell transplantation (allo-HSCT) has been performed [180–182].